Skip to main content
Caplight Logo









Seyltx, Inc.

Seyltx, Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.seyltx.com/

Last Round

Corporate Funding

Mar 27, 2024

Company Overview

Seyltx, Inc. is a clinical-stage biopharmaceutical company that develops innovative oral therapies for the treatment of refractory chronic cough and other neuronal hypersensitivity indications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalrefractory chronic coughRCCprecision medicinesmall moleculeNMDA receptor antagonistdrug developmentclinical trialspulmonary diseasecough suppressantbiotech startupdrug discoverytherapeutic assetsneuronal hypersensitivitynon-narcotic therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Seyltx, Inc. Comparables

Compare Seyltx, Inc. with similar companies based on industry and business-model similarity.

Seyltx, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axalbion
85%
Nocion Therapeutics
82%
Melius Pharma
79%

Seyltx, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMar 27, 2024

Key People

Founding team and executive leadership

Dietrich Stephan

Co-Founder. CEO And Chairman Of The Board

Founding Team

Seyltx, Inc. Filings

Explore SEC and related filing metadata, where available.

Seyltx, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Seyltx, Inc.'s valuation, stock price, and market status.

Is Seyltx, Inc. a public or private company?

Seyltx, Inc. is a private company.

What is the current stock price of Seyltx, Inc.?

Seyltx, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Seyltx, Inc. worth (valuation)?

Valuation information for Seyltx, Inc. is not publicly available.

Can I buy Seyltx, Inc. stock?

Seyltx, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Seyltx, Inc.'s last funding round?

Funding round information for Seyltx, Inc. is not publicly available.

Who are the main investors in Seyltx, Inc.?

Investor information for Seyltx, Inc. is not publicly disclosed.

Will Seyltx, Inc. IPO soon?

No public IPO plans have been announced for Seyltx, Inc..

How can I track Seyltx, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Seyltx, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range3
Year Founded2023
Last FundingMar 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?